Ecolab Inc (ECL) financial statements: income statement, balance sheet and cash flow
Ecolab Inc's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), Ecolab Inc reported revenue of $16.1B (+2.2% year on year) and net income of $2.1B (-1.7% year on year).
Income statement
Ecolab Inc income statement, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Dec 31, 2023 · FY
Dec 31, 2022 · FY
Net sales
$16.1B
$15.7B
$15.3B
$14.2B
Cost of sales (including special charges (a))
$8.9B
$8.9B
$9.2B
$8.8B
Selling, general and administrative expenses
$4.3B
$4.2B
$4.1B
$3.7B
Special (gains) and charges
$154.9M
($188.9M)
$111.4M
$140.5M
Operating income
$2.7B
$2.8B
$2.0B
$1.6B
Other (income) expense
($51.4M)
($51.3M)
($59.9M)
($24.5M)
Interest expense, net
$241.1M
$282.5M
$296.7M
$243.6M
Income before income taxes
$2.5B
$2.6B
$1.8B
$1.3B
Provision for income taxes
$454.6M
$439.3M
$362.5M
$234.5M
Net income including noncontrolling interest
$2.1B
$2.1B
$1.4B
—
Net income attributable to noncontrolling interest
$17.7M
$19.5M
$20.7M
—
Net income attributable to Ecolab
$2.1B
$2.1B
$1.4B
$1.1B
Basic (in dollars per share)
$7.33
$7.43
$4.82
$3.83
Diluted EPS (in dollars per share)
$7.28
$7.37
$4.79
$3.81
Basic (in shares)
283.3M
284.3M
285.0M
285.2M
Diluted (in shares)
285.2M
286.6M
286.5M
286.6M
Ecolab Inc income statement, quarters
Line item
Jun 30, 2026 · Q2
Mar 31, 2026 · Q1
Sep 30, 2025 · Q3
Jun 30, 2025 · Q2
Net sales
$4.4B
$4.1B
$4.2B
$4.0B
Cost of Sales
$2.5B
$2.3B
$2.3B
$2.2B
Selling, general and administrative expenses
$1.1B
$1.1B
$1.1B
$1.1B
Special (gains) and charges
$46.4M
$46.4M
$26.2M
$24.6M
Operating income
$757.9M
$622.0M
$760.2M
$710.1M
Other (income) expense
($8.8M)
($8.8M)
($12.8M)
($13.0M)
Interest expense, net (b)
$73.1M
$72.7M
$55.3M
$63.2M
Income before income taxes
$693.6M
$558.1M
$717.7M
$659.9M
Provision for income taxes
$154.9M
$121.5M
$128.0M
$131.4M
Net income including noncontrolling interest
$538.7M
$436.6M
$589.7M
$528.5M
Net income attributable to noncontrolling interest
$3.8M
$4.0M
$4.7M
$4.3M
Net income attributable to Ecolab
$534.9M
$432.6M
$585.0M
$524.2M
Basic (in dollars per share)
$1.91
$1.53
$2.06
$1.85
Diluted (in dollars per share)
$1.90
$1.52
$2.05
$1.84
Basic (in shares)
280.7M
282.0M
283.5M
283.5M
Diluted (in shares)
282.2M
283.7M
285.4M
285.4M
Balance sheet
Ecolab Inc balance sheet, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Dec 31, 2023 · FY
Dec 31, 2022 · FY
Cash and cash equivalents
$646.2M
$1.3B
$919.5M
$598.6M
Accounts receivable, net
$3.2B
$2.9B
$2.8B
$2.7B
Inventories
$1.5B
$1.5B
$1.5B
$1.8B
Other current assets
$569.6M
$439.0M
$393.2M
$404.7M
Total current assets
$6.0B
$6.0B
$5.6B
$5.5B
Property, plant and equipment, net
$4.3B
$3.8B
$3.5B
$3.3B
Goodwill
$9.2B
$7.9B
$8.1B
$8.0B
Other intangible assets, net
$3.7B
$3.3B
$3.5B
$3.7B
Operating lease assets
$765.9M
$723.2M
$553.5M
$448.2M
Other assets
$782.7M
$670.4M
$532.7M
$535.1M
Total assets
$24.7B
$22.4B
$21.8B
$21.5B
Short-term debt
$870.4M
$615.7M
$630.4M
$505.1M
Accounts payable
$2.1B
$1.8B
$1.6B
$1.7B
Compensation and benefits
$721.5M
$727.4M
$655.5M
$493.6M
Income taxes
$134.3M
$127.0M
$158.7M
$197.6M
Other current liabilities
$1.7B
$1.5B
$1.3B
$1.3B
Total current liabilities
$5.5B
$4.8B
$4.3B
$4.2B
Long-term debt
$7.4B
$6.9B
$7.6B
$8.1B
Pension and postretirement benefits
$546.1M
$634.9M
$651.7M
$670.3M
Deferred income taxes
$329.9M
$280.0M
$418.2M
$505.6M
Operating lease liabilities
$596.5M
$575.5M
$425.5M
$337.8M
Other liabilities
$518.7M
$366.2M
$381.8M
$406.3M
Total liabilities
$14.9B
$13.6B
$13.8B
$14.2B
Common stock
$369.4M
$367.8M
$365.7M
$364.7M
Additional paid-in capital
$7.5B
$7.2B
$6.8B
$6.6B
Retained earnings
$12.8B
$11.5B
$10.1B
$9.3B
Accumulated other comprehensive loss
($1.9B)
($2.0B)
($1.9B)
($1.7B)
Treasury stock
($9.1B)
($8.3B)
($7.3B)
($7.3B)
Total Ecolab shareholders' equity
$9.8B
$8.8B
$8.0B
$7.2B
Noncontrolling interest
$33.7M
$31.9M
$27.5M
$22.5M
Total equity
$9.8B
$8.8B
$8.1B
$7.3B
Total liabilities and equity
$24.7B
$22.4B
$21.8B
$21.5B
Ecolab Inc balance sheet, quarters
Line item
Jun 30, 2026
Mar 31, 2026
Sep 30, 2025
Jun 30, 2025
Cash and cash equivalents
$5.1B
$519.8M
$2.0B
$1.9B
Accounts receivable, net
$3.5B
$3.3B
$3.1B
$3.1B
Inventories
$1.6B
$1.6B
$1.5B
$1.6B
Other current assets
$787.9M
$670.7M
$501.9M
$526.6M
Total current assets
$11.0B
$6.0B
$7.1B
$7.1B
Property, plant and equipment, net
$4.4B
$4.4B
$4.1B
$3.9B
Goodwill
$9.4B
$9.4B
$8.1B
$8.0B
Other intangible assets, net
$3.4B
$3.5B
$3.1B
$3.2B
Operating lease assets
$747.2M
$775.1M
$767.7M
$762.8M
Other assets
$845.8M
$862.7M
$712.1M
$714.3M
Total assets
$29.9B
$25.0B
$23.9B
$23.7B
Short-term debt
$1.3B
$1.6B
$16.2M
$688.5M
Accounts payable
$2.2B
$2.1B
$1.9B
$1.9B
Compensation and benefits
$593.9M
$571.4M
$606.0M
$548.1M
Income taxes
$100.7M
$127.4M
$188.0M
$198.6M
Other current liabilities
$1.9B
$1.8B
$1.5B
$1.6B
Total current liabilities
$6.0B
$6.1B
$4.2B
$4.9B
Long-term debt
$11.9B
$6.9B
$8.1B
$7.5B
Pension and postretirement benefits
$533.8M
$547.6M
$597.8M
$617.1M
Deferred income taxes
$377.5M
$389.5M
$176.9M
$179.8M
Operating lease liabilities
$576.7M
$603.5M
$600.8M
$600.6M
Other liabilities
$462.9M
$449.8M
$527.3M
$557.2M
Total liabilities
$19.8B
$15.0B
$14.1B
$14.4B
Common stock
$370.2M
$370.2M
$369.1M
$368.8M
Additional paid-in capital
$7.7B
$7.6B
$7.4B
$7.4B
Retained earnings
$13.4B
$13.1B
$12.5B
$12.1B
Accumulated other comprehensive loss
($1.6B)
($1.6B)
($1.9B)
($2.0B)
Treasury stock
($9.7B)
($9.4B)
($8.7B)
($8.5B)
Total Ecolab shareholders’ equity
$10.1B
$10.0B
$9.7B
$9.3B
Noncontrolling interest
$28.9M
$28.1M
$34.9M
$30.3M
Total equity
$10.1B
$10.0B
$9.8B
$9.4B
Total liabilities and equity
$29.9B
$25.0B
$23.9B
$23.7B
Cash flow statement
Ecolab Inc cash flow statement, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Dec 31, 2023 · FY
Dec 31, 2022 · FY
Net income including noncontrolling interest
$2.1B
$2.1B
$1.4B
$1.1B
Depreciation
$672.6M
$634.9M
$616.7M
$618.5M
Amortization
$303.8M
$300.5M
$306.9M
$320.2M
Deferred income taxes
($33.4M)
($190.5M)
($55.7M)
($142.6M)
Share-based compensation expense
$136.6M
$134.8M
$95.1M
$87.8M
Pension and postretirement plan contributions
($77.8M)
($54.4M)
($109.3M)
($64.3M)
Pension and postretirement plan expense (income), net
$15.0M
$14.3M
$3.1M
$45.5M
Restructuring charges, net of cash paid
$18.8M
$23.7M
($32.6M)
$66.2M
Sale of global surgical solutions business
$1.1M
($381.7M)
—
—
Other, net
$28.8M
$24.3M
$31.9M
$24.9M
Accounts receivable
($185.9M)
($146.7M)
($84.3M)
($319.6M)
Inventories
$36.4M
($115.6M)
$320.3M
($402.9M)
Other assets
$83.6M
($24.3M)
$72.2M
($278.2M)
Accounts payable
$67.7M
$300.0M
($232.3M)
$394.7M
Other liabilities
($208.0M)
$162.7M
$86.8M
$329.3M
Cash provided by operating activities
$3.0B
$2.8B
$2.4B
$1.8B
Capital expenditures
($1.0B)
($994.5M)
($774.8M)
($712.8M)
Property and other assets sold
$52.3M
$11.3M
$9.9M
$2.2M
Acquisitions and investments in affiliates, net of cash acquired
($1.6B)
($312.9M)
($180.4M)
($7.2M)
Divestiture of businesses, net of cash divested
($14.9M)
$889.7M
—
—
Other, net
($75.0M)
($27.4M)
($45.2M)
$1.0M
Cash used for investing activities
($2.7B)
($433.8M)
($990.5M)
($716.8M)
Net issuances (repayments) of commercial paper and notes payable
$98.2M
$1.9M
($1.9M)
($404.3M)
Long-term debt borrowings
$1.0B
—
—
$494.0M
Long-term debt repayments
($674.2M)
($630.4M)
($500.0M)
—
Reacquired shares
-783.8M
-986.5M
-13.7M
-518.2M
Dividends paid
($753.6M)
($664.3M)
($617.3M)
($602.8M)
Exercise of employee stock options
$228.2M
$259.4M
$96.8M
$29.1M
Other, net
($13.7M)
($3.6M)
($3.3M)
($7.1M)
Cash used for financing activities
($853.3M)
($2.0B)
($1.1B)
($837.3M)
Effect of exchange rate changes on cash and cash equivalents
($2.7M)
($18.7M)
($45.7M)
$4.4M
(Decrease) Increase in cash and cash equivalents
($610.6M)
$337.3M
—
—
Cash and cash equivalents, beginning of period
$1.3B
$919.5M
$598.6M
$359.9M
Cash and cash equivalents, end of period
$646.2M
$1.3B
$919.5M
$598.6M
Income taxes paid
$548.1M
$647.4M
$469.2M
$308.9M
Net interest paid
$302.6M
$342.6M
$324.8M
$222.4M
Ecolab Inc cash flow statement, quarters
Line item
Jun 30, 2026 · YTD
Mar 31, 2026 · Q1
Sep 30, 2025 · YTD
Jun 30, 2025 · YTD
Net income including noncontrolling interest
$975.3M
$436.6M
$1.5B
$935.0M
Depreciation
$364.3M
$180.5M
$493.8M
$327.9M
Amortization
$167.7M
$82.6M
$226.5M
$149.9M
Deferred income taxes
$34.9M
$19.4M
($57.1M)
($60.7M)
Share-based compensation expense
$75.1M
$40.3M
$109.5M
$75.9M
Pension and postretirement plan contributions
($32.8M)
($18.1M)
($67.1M)
($29.0M)
Pension and postretirement plan (income) expense, net
$18.9M
$9.1M
$10.4M
$6.9M
Restructuring charges, net of cash paid
($2.8M)
$3.5M
($12.5M)
$5.4M
Sale of global surgical solutions business
$0
—
$1.1M
$1.1M
Other, net
$28.1M
$10.6M
$20.4M
$6.8M
Accounts receivable
($197.0M)
$13.5M
($150.3M)
($122.4M)
Inventories
($131.4M)
($47.3M)
($37.6M)
($76.9M)
Other assets
($208.6M)
($117.2M)
$34.1M
$22.3M
Accounts payable
$146.3M
$15.5M
($47.8M)
$7.4M
Other liabilities
($62.6M)
($183.1M)
($185.6M)
($178.4M)
Cash provided by operating activities
$1.2B
$445.9M
$1.9B
$1.1B
Capital expenditures
($588.6M)
($348.5M)
($716.2M)
($454.6M)
Property and other assets sold
$2.0M
$200.0K
$46.4M
$42.4M
Acquisitions and investments in affiliates, net of cash acquired
($27.0M)
—
($500.0K)
($500.0K)
Divestiture of businesses, net of cash divested
$0
—
($14.9M)
($14.9M)
Other, net
($15.9M)
($7.2M)
($43.8M)
($20.8M)
Cash used for investing activities
($629.5M)
($355.5M)
($729.0M)
($448.4M)
Net repayments of commercial paper and notes payable
($98.2M)
$201.6M
$1.1M
($800.0K)
Long-term debt borrowings
$5.1B
$53.0M
$1.0B
$500.0M
Reacquired shares
-669.3M
-344.4M
-374.6M
-199.2M
Dividends paid
($424.1M)
($215.9M)
($564.4M)
($380.0M)
Exercise of employee stock options
$94.8M
$83.5M
$182.0M
$139.0M
Deferred financing costs
($49.2M)
—
—
—
Other, net
($6.6M)
($3.6M)
($10.6M)
($3.3M)
Cash provided by financing activities
$3.9B
($225.8M)
($421.7M)
$55.7M
Effect of exchange rate changes on cash and cash equivalents